Live
- Time is right for BJP to make an entry into Kerala: Amit Shah
- REC okays Rs 1,869 crore loan for Kiru hydro project in J&K
- Nepal, Qatar agree to increase cooperation in various sectors
- 10 Effective and Gentle Techniques to Discipline Kids
- Six-year-old girl allegedly molested by tuition teacher's son in south Delhi
- Recording co's appeal in Madras HC casts a shadow on Ilaiyaraaja's 4.5K songs
- Turkish police detain 11 suspected IS members
- Vice FMs of South Korea, Canada discuss cooperation in energy, G7 ties
- HUL posts 6 pc fall in Q4 net profit at Rs 2,406 crore, declares dividend of Rs 24 per share
- Zimbabwe name 15-member squad for five-match T20I series against Bangladesh
Aurobindo Pharma gets FDA nod for new drug
Highlights
Drug major Aurobindo Pharma has received final approval from the USFDA to manufacture and market Azithromycin tablets, used for the treatment of patients with mild to moderate infections, in the US market
Hyderabad: Drug major Aurobindo Pharma has received final approval from the USFDA to manufacture and market Azithromycin tablets, used for the treatment of patients with mild to moderate infections, in the US market.
The approval has been granted in the strengths of 250 mg and 500 mg, and the product will be launched this month, Aurobindo Pharma said. The approved product is generic equivalent of Pfizer Inc's Zithromax tablet, it added.
Quoting IQVIA sales data, the company said, the approved product has an estimated market size of $132 million for the 12 months ending May 2018. Aurobindo Pharma currently has a total of 337 ANDA approvals from the US.
Next Story
ADVERTISEMENT
